<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1471-2180-2-35.anc" start="25738" end="25742" sStart="25512" offset="226" sid="r8.way.n.0560" wn="2" wnkey="way%1:04:01::" text="The preceding discussion indicates that the resistance competition assay is consistent with other measures of phage performance in vivo and provides specific insights not easily obtained in other ways." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1471-2180-2-35.anc" start="27486" end="27491" sStart="null" offset="0" sid="null" wn="3" wnkey="time%1:28:00::" text="(4) The RCA can be applied to populations of bacteria infecting specific tissues at specific &lt;b&gt;times&lt;/b&gt;, even allowing multiple measures per animal." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2180-2-35.anc" start="30226" end="30235" sStart="null" offset="23" sid="r8.suggest.v.0780" wn="3" wnkey="suggest%2:32:02::" text="Moreover, as suggested in a recent study [ 12 ] , in vivo culture may selectively improve the capacity of a phage to replicate on and kill bacteria in a mammalian host." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="591" end="600" sStart="null" offset="0" sid="null" wn="2" wnkey="success%1:04:00::" text="The use of bacteriophage for the treatment of bacterial infections is an old idea [ 4 ] that not only caught the imagination of at least one novelist [ 5 ] it was practiced with sporadic &lt;b&gt;successes&lt;/b&gt; worldwide in the 1920s and 1930s." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="18557" end="18564" sStart="null" offset="0" sid="null" wn="2" wnkey="success%1:04:00::" text="(i) Phages vary in treatment &lt;b&gt;success&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="591" end="600" sStart="null" offset="0" sid="null" wn="2" wnkey="success%1:04:00::" text="The use of bacteriophage for the treatment of bacterial infections is an old idea [ 4 ] that not only caught the imagination of at least one novelist [ 5 ] it was practiced with sporadic &lt;b&gt;successes&lt;/b&gt; worldwide in the 1920s and 1930s." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="591" end="600" sStart="null" offset="0" sid="null" wn="2" wnkey="success%1:04:00::" text="The use of bacteriophage for the treatment of bacterial infections is an old idea [ 4 ] that not only caught the imagination of at least one novelist [ 5 ] it was practiced with sporadic &lt;b&gt;successes&lt;/b&gt; worldwide in the 1920s and 1930s." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="591" end="600" sStart="null" offset="0" sid="null" wn="2" wnkey="success%1:04:00::" text="The use of bacteriophage for the treatment of bacterial infections is an old idea [ 4 ] that not only caught the imagination of at least one novelist [ 5 ] it was practiced with sporadic &lt;b&gt;successes&lt;/b&gt; worldwide in the 1920s and 1930s." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="591" end="600" sStart="null" offset="0" sid="null" wn="1" wnkey="success%1:11:00::" text="The use of bacteriophage for the treatment of bacterial infections is an old idea [ 4 ] that not only caught the imagination of at least one novelist [ 5 ] it was practiced with sporadic &lt;b&gt;successes&lt;/b&gt; worldwide in the 1920s and 1930s." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="18557" end="18564" sStart="null" offset="0" sid="null" wn="2" wnkey="success%1:04:00::" text="(i) Phages vary in treatment &lt;b&gt;success&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="591" end="600" sStart="null" offset="0" sid="null" wn="1" wnkey="success%1:11:00::" text="The use of bacteriophage for the treatment of bacterial infections is an old idea [ 4 ] that not only caught the imagination of at least one novelist [ 5 ] it was practiced with sporadic &lt;b&gt;successes&lt;/b&gt; worldwide in the 1920s and 1930s." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="18557" end="18564" sStart="null" offset="0" sid="null" wn="1" wnkey="success%1:11:00::" text="(i) Phages vary in treatment &lt;b&gt;success&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="591" end="600" sStart="null" offset="0" sid="null" wn="1" wnkey="success%1:11:00::" text="The use of bacteriophage for the treatment of bacterial infections is an old idea [ 4 ] that not only caught the imagination of at least one novelist [ 5 ] it was practiced with sporadic &lt;b&gt;successes&lt;/b&gt; worldwide in the 1920s and 1930s." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="591" end="600" sStart="null" offset="0" sid="null" wn="" wnkey="null" text="The use of bacteriophage for the treatment of bacterial infections is an old idea [ 4 ] that not only caught the imagination of at least one novelist [ 5 ] it was practiced with sporadic &lt;b&gt;successes&lt;/b&gt; worldwide in the 1920s and 1930s." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="22533" end="22538" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" text="In their now classical investigations of the within-host dynamics of antibiotic treatment, they followed the course of penicillin treatment of Treponema pallidum and Group A and Group B Streptococcus [ 26 27 28 ] . Eagle [ 28 ] postulated that the most likely reason for the declining efficacy of treatment with the term of the infection was due to (i) a decline in the &lt;b&gt;rate&lt;/b&gt; of metabolism and replication of bacteria during the infection, and (ii) that slowly growing or non-growing bacteria are more refractory to penicillin than those that replicating at higher &lt;b&gt;rates&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="4555" end="4559" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" text="The other method is a simple procedure to assay phage growth &lt;b&gt;rate&lt;/b&gt; in vitro that can be used to screen phages to evaluate their potential for therapy." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="11166" end="11171" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" text="This substitution controls for intrinsic differences in fitness of the two bacteria, for differences in the physiological states of the bacteria at the time of inoculation that could affect their growth &lt;b&gt;rates&lt;/b&gt; independent of treatment, and for possible differences in the host response with and without treatment." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="14164" end="14169" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" text="Mortality &lt;b&gt;rates&lt;/b&gt; of mice in Smith and Huggins [ 18 ] and here, as well as the RCA values, indicate that phages specific for the K1-capsule are more effective in controlling the infections than phage that are not specific for the capsule." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="43152" end="43156" sStart="null" offset="0" sid="null" wn="3" wnkey="rate%1:07:00::" text="The principle underlying this assay is that bacteria resistant to a treatment will increase in frequency over sensitive bacteria only to the extent that the treatment is effective at killing or reducing the &lt;b&gt;rate&lt;/b&gt; of growth of the sensitive bacteria." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="22533" end="22538" sStart="null" offset="0" sid="null" wn="1" wnkey="rate%1:28:00::" text="In their now classical investigations of the within-host dynamics of antibiotic treatment, they followed the course of penicillin treatment of Treponema pallidum and Group A and Group B Streptococcus [ 26 27 28 ] . Eagle [ 28 ] postulated that the most likely reason for the declining efficacy of treatment with the term of the infection was due to (i) a decline in the &lt;b&gt;rate&lt;/b&gt; of metabolism and replication of bacteria during the infection, and (ii) that slowly growing or non-growing bacteria are more refractory to penicillin than those that replicating at higher &lt;b&gt;rates&lt;/b&gt;." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="4555" end="4559" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" text="The other method is a simple procedure to assay phage growth &lt;b&gt;rate&lt;/b&gt; in vitro that can be used to screen phages to evaluate their potential for therapy." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="11166" end="11171" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" text="This substitution controls for intrinsic differences in fitness of the two bacteria, for differences in the physiological states of the bacteria at the time of inoculation that could affect their growth &lt;b&gt;rates&lt;/b&gt; independent of treatment, and for possible differences in the host response with and without treatment." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="14164" end="14169" sStart="null" offset="0" sid="null" wn="4" wnkey="rate%1:24:00::" text="Mortality &lt;b&gt;rates&lt;/b&gt; of mice in Smith and Huggins [ 18 ] and here, as well as the RCA values, indicate that phages specific for the K1-capsule are more effective in controlling the infections than phage that are not specific for the capsule." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="43152" end="43156" sStart="null" offset="0" sid="null" wn="3" wnkey="rate%1:07:00::" text="The principle underlying this assay is that bacteria resistant to a treatment will increase in frequency over sensitive bacteria only to the extent that the treatment is effective at killing or reducing the &lt;b&gt;rate&lt;/b&gt; of growth of the sensitive bacteria." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="32591" end="32596" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="And as procedures to identify the bacteria responsible for symptomatic infections get better and more &lt;b&gt;rapid&lt;/b&gt;, it soon may be quite easy to get this information from individual patients." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="32591" end="32596" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="And as procedures to identify the bacteria responsible for symptomatic infections get better and more &lt;b&gt;rapid&lt;/b&gt;, it soon may be quite easy to get this information from individual patients." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="32591" end="32596" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="And as procedures to identify the bacteria responsible for symptomatic infections get better and more &lt;b&gt;rapid&lt;/b&gt;, it soon may be quite easy to get this information from individual patients." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="32591" end="32596" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="And as procedures to identify the bacteria responsible for symptomatic infections get better and more &lt;b&gt;rapid&lt;/b&gt;, it soon may be quite easy to get this information from individual patients." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="32591" end="32596" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="And as procedures to identify the bacteria responsible for symptomatic infections get better and more &lt;b&gt;rapid&lt;/b&gt;, it soon may be quite easy to get this information from individual patients." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="32591" end="32596" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="And as procedures to identify the bacteria responsible for symptomatic infections get better and more &lt;b&gt;rapid&lt;/b&gt;, it soon may be quite easy to get this information from individual patients." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="32591" end="32596" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="And as procedures to identify the bacteria responsible for symptomatic infections get better and more &lt;b&gt;rapid&lt;/b&gt;, it soon may be quite easy to get this information from individual patients." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="32591" end="32596" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="And as procedures to identify the bacteria responsible for symptomatic infections get better and more &lt;b&gt;rapid&lt;/b&gt;, it soon may be quite easy to get this information from individual patients." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="32591" end="32596" sStart="null" offset="0" sid="null" wn="1" wnkey="rapid%5:00:00:fast:01" text="And as procedures to identify the bacteria responsible for symptomatic infections get better and more &lt;b&gt;rapid&lt;/b&gt;, it soon may be quite easy to get this information from individual patients." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2180-2-35.anc" start="9909" end="9914" sStart="null" offset="67" sid="null" wn="1" wnkey="kill%2:35:00::" text="Assuming that cells are not growing and that treatment kills sensitive cells, an RCA of 0 means that sensitive cells are not killed, an RCA of 1 means that 63% of sensitive cells are killed per hour (95% in 3 hours), and an RCA of 2 means that 86." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2180-2-35.anc" start="9909" end="9914" sStart="null" offset="67" sid="null" wn="1" wnkey="kill%2:35:00::" text="Assuming that cells are not growing and that treatment kills sensitive cells, an RCA of 0 means that sensitive cells are not killed, an RCA of 1 means that 63% of sensitive cells are killed per hour (95% in 3 hours), and an RCA of 2 means that 86." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2180-2-35.anc" start="9909" end="9914" sStart="null" offset="67" sid="null" wn="1" wnkey="kill%2:35:00::" text="Assuming that cells are not growing and that treatment kills sensitive cells, an RCA of 0 means that sensitive cells are not killed, an RCA of 1 means that 63% of sensitive cells are killed per hour (95% in 3 hours), and an RCA of 2 means that 86." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2180-2-35.anc" start="9909" end="9914" sStart="null" offset="67" sid="null" wn="1" wnkey="kill%2:35:00::" text="Assuming that cells are not growing and that treatment kills sensitive cells, an RCA of 0 means that sensitive cells are not killed, an RCA of 1 means that 63% of sensitive cells are killed per hour (95% in 3 hours), and an RCA of 2 means that 86." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2180-2-35.anc" start="9909" end="9914" sStart="null" offset="67" sid="null" wn="1" wnkey="kill%2:35:00::" text="Assuming that cells are not growing and that treatment kills sensitive cells, an RCA of 0 means that sensitive cells are not killed, an RCA of 1 means that 63% of sensitive cells are killed per hour (95% in 3 hours), and an RCA of 2 means that 86." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2180-2-35.anc" start="9909" end="9914" sStart="null" offset="67" sid="null" wn="3" wnkey="kill%2:30:08::" text="Assuming that cells are not growing and that treatment kills sensitive cells, an RCA of 0 means that sensitive cells are not killed, an RCA of 1 means that 63% of sensitive cells are killed per hour (95% in 3 hours), and an RCA of 2 means that 86." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2180-2-35.anc" start="32619" end="32623" sStart="null" offset="150" sid="r7.1.easy.j.0262" wn="1" wnkey="easy%3:00:01::" text="And as procedures to identify the bacteria responsible for symptomatic infections get better and more rapid, it soon may be quite easy to get this information from individual patients." />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2180-2-35.anc" start="44142" end="44151" sStart="null" offset="173" sid="r8.1.different.j.0945" wn="4" wnkey="different%5:00:01:other:00" text="We applied this assay in two ways: 1) By using different mice for the immediate and delayed treatments or, 2) by inoculating the same mouse in different hind limb thighs, with the second inoculation delayed 8 hours, and treating the mouse immediately by inoculation of streptomycin, phage or saline into the musculature of a forelimb" />
    <s path="[OANC]/data/written_2/technical/biomed/1471-2180-2-35.anc" start="26098" end="26107" sStart="null" offset="210" sid="r8.1.different.j.0316" wn="1" wnkey="different%3:00:00::" text="In addition to being used to study the population dynamics of phage and antibiotic treatment in general, the RCA could be employed to design and evaluate the efficacy of different antibiotic treatment protocols." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="22889" end="22895" sStart="null" offset="0" sid="null" wn="1" wnkey="become%2:30:00::" text="More recent work by E. Tuomanen, A. Tomaz and their colleagues supported this interpretation, a phenomenon they called phenotypic tolerance [ 29 30 31 ] . They also provided evidence that nutrient limitation was the cause of the decline in the rate of bacterial growth [ 32 ] . Not only do bacteria &lt;b&gt;become&lt;/b&gt; increasingly refractory to the majority of antibiotics as their rate of growth declines, but they also adsorb to and replicate bacteriophage less efficiently [ 24 33 ] , as is evident from the PRA values in Fig." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="22889" end="22895" sStart="null" offset="0" sid="null" wn="1" wnkey="become%2:30:00::" text="More recent work by E. Tuomanen, A. Tomaz and their colleagues supported this interpretation, a phenomenon they called phenotypic tolerance [ 29 30 31 ] . They also provided evidence that nutrient limitation was the cause of the decline in the rate of bacterial growth [ 32 ] . Not only do bacteria &lt;b&gt;become&lt;/b&gt; increasingly refractory to the majority of antibiotics as their rate of growth declines, but they also adsorb to and replicate bacteriophage less efficiently [ 24 33 ] , as is evident from the PRA values in Fig." />
    <s path="file:/D:/Corpora/oanc/data/written_2/technical/biomed/1471-2180-2-35.anc" start="45468" end="45473" sStart="null" offset="0" sid="null" wn="1" wnkey="add%2:30:00::" text="Aliquots of 1 ml of the growing bacterial cultures were &lt;b&gt;added&lt;/b&gt; to empty tubes along with the phage." />
  </sentences>
</list>